| Clay City Center For Family Medicine | |
|
315 Lankford St Clay City IN 47841-1008 | |
| (812) 939-2126 | |
| Not Available |
| Full Name | Clay City Center For Family Medicine |
|---|---|
| Speciality | Clinic/Center |
| Location | 315 Lankford St, Clay City, Indiana |
| Authorized Official Name and Position | Steve Holman (CEO) |
| Authorized Official Contact | 8122387606 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Clay City Center For Family Medicine Po Box 2505 Indianapolis IN 46206-2505 Ph: (812) 238-7783 | Clay City Center For Family Medicine 315 Lankford St Clay City IN 47841-1008 Ph: (812) 939-2126 |
| NPI Number | 1235120882 |
|---|---|
| Provider Enumeration Date | 11/02/2005 |
| Last Update Date | 07/20/2023 |
| Medicare PECOS PAC ID | 8426943614 |
|---|---|
| Medicare Enrollment ID | O20070626000727 |
News Archive
An ongoing Arizona State University effort to develop a revolutionary class of reagents that holds great promise for the future of medicine has received a major boost with a three-year, $4 million award from the National Institutes of Health.
Exercise can buffer the effects of stress-induced cell aging, according to new research from UCSF that revealed actual benefits of physical activity at the cellular level.
HCP announced that it closed the acquisition of 334 post-acute, skilled nursing and assisted living facilities of HCR ManorCare for a total consideration of $6.1 billion in cash. In connection with the closing, HCP entered into a long-term triple-net master lease under which HCR ManorCare will continue to operate the facilities.
Researchers at Mount Sinai School of Medicine have identified a new drug target that may treat and/or prevent heart failure. The team evaluated failing human and pig hearts and discovered that SUMO1, a so-called "chaperone" protein that regulates the activity of key transporter genes, was decreased in failing hearts.
A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235120882 | NPI | - | NPPES |
| 100079350 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
An ongoing Arizona State University effort to develop a revolutionary class of reagents that holds great promise for the future of medicine has received a major boost with a three-year, $4 million award from the National Institutes of Health.
Exercise can buffer the effects of stress-induced cell aging, according to new research from UCSF that revealed actual benefits of physical activity at the cellular level.
HCP announced that it closed the acquisition of 334 post-acute, skilled nursing and assisted living facilities of HCR ManorCare for a total consideration of $6.1 billion in cash. In connection with the closing, HCP entered into a long-term triple-net master lease under which HCR ManorCare will continue to operate the facilities.
Researchers at Mount Sinai School of Medicine have identified a new drug target that may treat and/or prevent heart failure. The team evaluated failing human and pig hearts and discovered that SUMO1, a so-called "chaperone" protein that regulates the activity of key transporter genes, was decreased in failing hearts.
A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term.
› Verified 1 days ago